Mutual of America Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Sell
33,255
-26,606
-44% -$1.44M 0.02% 752
2026
Q1
$3.13M Sell
59,861
-250
-0.4% -$15K 0.04% 568
2025
Q4
$3.54M Buy
60,111
+3,401
+6% +$207K 0.04% 561
2025
Q3
$3.15M Buy
56,710
+3,843
+7% +$206K 0.03% 614
2025
Q2
$2.72M Sell
52,867
-2,626
-5% -$132K 0.03% 696
2025
Q1
$3.25M Buy
55,493
+12,740
+30% +$863K 0.04% 622
2024
Q4
$3.08M Buy
42,753
+1,080
+3% +$79.3K 0.03% 686
2024
Q3
$3.33M Buy
41,673
+8,852
+27% +$665K 0.04% 672
2024
Q2
$2.35M Buy
32,821
+12,234
+59% +$900K 0.03% 809
2024
Q1
$1.45M Sell
20,587
-547
-3% -$39.1K 0.02% 988
2023
Q4
$1.63M Sell
21,134
-872
-4% -$57.4K 0.02% 970
2023
Q3
$1.5M Sell
22,006
-614
-3% -$48.5K 0.02% 969
2023
Q2
$1.85M Buy
22,620
+181
+0.8% +$14.5K 0.02% 939
2023
Q1
$1.66M Buy
22,439
+40
+0.2% +$3.08K 0.02% 956
2022
Q4
$1.86M Buy
22,399
+695
+3% +$55.2K 0.02% 921
2022
Q3
$1.54M Buy
21,704
+324
+2% +$28K 0.02% 945
2022
Q2
$1.85M Buy
21,380
+428
+2% +$40.1K 0.02% 906
2022
Q1
$2.27M Buy
20,952
+220
+1% +$22.7K 0.02% 907
2021
Q4
$2.68M Buy
20,732
+348
+2% +$42.7K 0.03% 878
2021
Q3
$2.47M Sell
20,384
-116,692
-85% -$14.2M 0.02% 886
2021
Q2
$15.4M Sell
137,076
-2,504
-2% -$264K 0.15% 104
2021
Q1
$13.3M Sell
139,580
-4,128
-3% -$377K 0.14% 116
2020
Q4
$11.4M Sell
143,708
-160
-0.1% -$11.6K 0.13% 139
2020
Q3
$8.91M Buy
143,868
+1,256
+0.9% +$81.7K 0.12% 161
2020
Q2
$9.41M Buy
142,612
+788
+0.6% +$47.2K 0.13% 132
2020
Q1
$6.72M Buy
141,824
+4,672
+3% +$234K 0.11% 193
2019
Q4
$7.53M Buy
137,152
+1,348
+1% +$70.7K 0.1% 251
2019
Q3
$6.64M Buy
135,804
+804
+0.6% +$40.3K 0.09% 265
2019
Q2
$7.04M Buy
135,000
+1,996
+2% +$101K 0.1% 240
2019
Q1
$6.6M Sell
133,004
-924
-0.7% -$41.6K 0.1% 255
2018
Q4
$4.85M Buy
133,928
+5,808
+5% +$243K 0.08% 340
2018
Q3
$6.54M Sell
128,120
-748
-0.6% -$33.1K 0.09% 280
2018
Q2
$4.77M Buy
128,868
+5,460
+4% +$208K 0.07% 419
2018
Q1
$4.66M Buy
123,408
+1,848
+2% +$65.3K 0.07% 419
2017
Q4
$3.94M Sell
121,560
-152
-0.1% -$4.83K 0.06% 529
2017
Q3
$3.68M Buy
121,712
+1,016
+0.8% +$30.1K 0.06% 526
2017
Q2
$3.54M Buy
120,696
+4,252
+4% +$116K 0.06% 527
2017
Q1
$2.96M Buy
116,444
+1,896
+2% +$48.9K 0.05% 612
2016
Q4
$2.94M Buy
114,548
+1,728
+2% +$45.4K 0.06% 579
2016
Q3
$3.09M Buy
112,820
+2,304
+2% +$63.3K 0.06% 524
2016
Q2
$3.12M Buy
110,516
+7,312
+7% +$188K 0.07% 473
2016
Q1
$2.44M Buy
103,204
+992
+1% +$21.8K 0.05% 564
2015
Q4
$2.3M Buy
102,212
+3,864
+4% +$88.1K 0.05% 597
2015
Q3
$2.27M Buy
98,348
+2,660
+3% +$66.7K 0.05% 577
2015
Q2
$2.36M Sell
95,688
-1,980
-2% -$49.4K 0.05% 628
2015
Q1
$2.45M Buy
97,668
+4,164
+4% +$99K 0.05% 616
2014
Q4
$2.16M Buy
93,504
+1,060
+1% +$24.3K 0.05% 669
2014
Q3
$2.16M Buy
92,444
+10,088
+12% +$236K 0.05% 617
2014
Q2
$1.91M Sell
82,356
-1,604
-2% -$35.4K 0.04% 717
2014
Q1
$1.79M Buy
83,960
+4,932
+6% +$111K 0.04% 719
2013
Q4
$1.87M Buy
79,028
+1,364
+2% +$29.6K 0.05% 695
2013
Q3
$1.55M Sell
77,664
-3,424
-4% -$65K 0.04% 728
2013
Q2
$1.4M Buy
+81,088
New +$1.35M 0.04% 740

Other funds holding TECH

Mutual of America Capital Management's TECH Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Bio-Techne (TECH) stake by 44% in Q2 2026, selling an estimated $1.44M and leaving 33,255 shares worth $2.35M. The position accounts for 0.02% of the portfolio, ranked #752.

Mutual of America Capital Management first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.4M in Q2 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Mutual of America Capital Management held 33,255 shares of Bio-Techne worth $2.35M as of Q2 2026.
  • Mutual of America Capital Management sold 26,606 Bio-Techne shares in Q2 2026, an estimated $1.44M.
  • Bio-Techne made up 0.02% of Mutual of America Capital Management's portfolio in Q2 2026, its #752 holding.
  • Mutual of America Capital Management first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • Mutual of America Capital Management's Bio-Techne position peaked at $15.4M in Q2 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.